Cargando…
Author Correction: A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment
Autores principales: | Guyot, Anne-Cécile, Leuxe, Charlotte, Disdier, Clémence, Oumata, Nassima, Costa, Narciso, Le Roux, Gwenaëlle, Varela, Paloma F., Duchon, Arnaud, Charbonnier, Jean Baptiste, Herault, Yann, Pavoni, Serena, Galons, Hervé, Andriambeloson, Emile, Wagner, Stéphanie, Meijer, Laurent, Lund, Amie K., Mabondzo, Aloïse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335037/ https://www.ncbi.nlm.nih.gov/pubmed/32620926 http://dx.doi.org/10.1038/s41598-020-67127-x |
Ejemplares similares
-
A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment
por: Guyot, Anne-Cécile, et al.
Publicado: (2020) -
Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines
por: Troadec, Samuel, et al.
Publicado: (2015) -
Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
por: Disdier, Clémence, et al.
Publicado: (2015) -
A Simple Isomerization of the Purine Scaffold of a
Kinase Inhibitor, Roscovitine, Affords a Four- to Seven-Fold Enhancement
of Its Affinity for Four CDKs. Could This Be Traced Back to Conjugation-Induced
Stiffenings/Loosenings of Rotational Barriers?
por: El Hage, Krystel, et al.
Publicado: (2017) -
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model
por: Roux, Gwenaëlle Le, et al.
Publicado: (2019)